Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma

被引：0
作者：
Y. Zhang
Q. Zhai
X. Feng
D. Chen
Y. Lu
J. Hu
H. Xie
L. Zhou
J. Wu
S. Zheng
机构：
[1] Zhejiang University,Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine
[2] NHC Key Laboratory of Combined Multi-Organ Transplantation,Key Laboratory of the Diagnosis and Treatment of Organ Transplantation
[3] CAMS,Department of Anesthesiology & Center for Brain Science, The First Affiliated Hospital
[4] Key Laboratory of Organ Transplantation,undefined
[5] Xi’an Jiaotong University,undefined
[6] Zhejiang Provincial Research Center for Diagnosis and Treatment of Heapatobiliary Diseases,undefined
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
STING; Hepatocellular carcinoma; CD8 + T cell; Immunotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1314 / 1324
页数：10
相关论文
共 50 条
  • [1] Cancer cell-intrinsic STING is associated with CD8+T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma
    Zhang, Y.
    Zhai, Q.
    Feng, X.
    Chen, D.
    Lu, Y.
    Hu, J.
    Xie, H.
    Zhou, L.
    Wu, J.
    Zheng, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (07) : 1314 - 1324
  • [2] Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer
    Xue, Junli
    Yu, Xuetao
    Xue, Liqiong
    Ge, Xiaoxiao
    Zhao, Wei
    Peng, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [3] Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
    Huo, Junyu
    Wu, Liqun
    Zang, Yunjin
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [4] Analysis of cancer cell-intrinsic immune regulation in response to CD8+T cell attack
    Neubert, Natalie J.
    Tille, Laure
    Martignier, Christophe
    Marraco, Silvia A. Fuertes
    Speiser, Daniel E.
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - CELLULAR METHODS, PT A, 2020, 631 : 443 - 466
  • [5] Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
    Shigeta, Kohei
    Matsui, Aya
    Kikuchi, Hiroto
    Klein, Sebastian
    Mamessier, Emilie
    Chen, Ivy X.
    Aoki, Shuichi
    Kitahara, Shuji
    Inoue, Koetsu
    Shigeta, Ayako
    Hato, Tai
    Ramjiawan, Rakesh R.
    Staiculescu, Daniel
    Zopf, Dieter
    Fiebig, Lukas
    Hobbs, Gabriela S.
    Quaas, Alexander
    Dima, Simona
    Popescu, Irinel
    Huang, Peigen
    Munn, Lance L.
    Cobbold, Mark
    Goyal, Lipika
    Zhu, Andrew X.
    Jain, Rakesh K.
    Duda, Dan G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [6] Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma
    Shahriar Behboudi
    Stephen P Pereira
    World Journal of Hepatology, 2010, 2 (07) : 256 - 260
  • [7] Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma
    Behboudi, Shahriar
    Pereira, Stephen P.
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (07) : 256 - 260
  • [8] Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
    Junyu Huo
    Liqun Wu
    Yunjin Zang
    BMC Medical Genomics, 14
  • [9] Prognostic Significance of CD4+ and CD8+ T Cell Infiltration Within Cancer Cell Nests in Vulvar Squamous Cell Carcinoma
    Sznurkowski, Jacek Jan
    Zawrocki, Anton
    Emerich, Janusz
    Biernat, Wojciech
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 717 - 721
  • [10] STAT4, a potential predictor of prognosis, promotes CD8 T-cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion
    Wang, Wei
    Liu, Si
    Lu, Funian
    Yang, Bin
    Zhuang, Xucui
    Yin, Jingjing
    Chen, Gang
    Sun, Chaoyang
    ONCOLOGY REPORTS, 2023, 50 (01)
12345